About this trial
The aim of the study is to compare the effect of nebulized Dexmedetomidine compared to nebulized Lidocaine on postoperative sore throat in childern undergoing Tonsillectomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: Childern between 3:15 years old
American Society of Anesthesiologists(ASA) Physical Status I or II
Elective Tonsillectomy
Disqualifiers
Parents refusal
Presence of preoperative sore throat
Known allergy to the study drug
History of upper respiratory tract infection 2 weeks prior to surgery
Trial design
Parallel
Treatments tested in this trial
Group D (dexmedetomidine group)
Druggroup D (Dexmedetomidine group) will recieve a dose of 1 mcg/kg
Group L (Lidocaine group)
Drugwill recieve Lidocaine 2%, 1 mg/kg
Treatment groups
Trial outcomes
Primary outcomes
Incidence of Postoperative Sore Throat (POST)
Secondary outcomes
Severity of sore throat (ST)
specifically at the 4th postoperative hour. ST was scored on a four-point scale (0-3) (20) 0 =No ST 1. =mild ST (complains of ST only on asking); 2. =moderate ST (complains of ST on his/her own) 3. =severe ST (change in voice or hoarseness, associated with throat pain).
*Hemodynamic Parameters
Heart Rate
Hemodynamic Parameters
Mean Arterial Blood Pressure
Hemodynamic Parameters
Oxygen Saturation ( SPO2 )
Sponsors and contacts
Click on the lead sponsor to view all of their trials.